Table 2 Demographic characterization of FHS participants.
Participant characteristics | FHS |
|---|---|
No. subjects | 1913 |
Women | 1024 (53.5) |
Age, years | 55 (47,63) |
HDL-C, mg/dl | 48 (39,59) (n = 1907) |
LDL-C, mg/dl | 125 [104, 146] (n = 1855) |
Triglycerides, mg/dl | 121 [85, 179] (n = 1913) |
BMI, kg/m2 | 26.7 [24.0, 29.9] (n = 1910) |
fasting glucose | 95 [89, 104] (n = 1897) |
Systolic blood pressure (SBP), mmHg | 124 [113, 138] (n = 1913) |
Diastolic blood pressure (DBP), mmHg | 74 [68,81] (n = 1913) |
Current smoke (yes/no) | 370 (19.3) (n = 1912) |
Lipid medication (yes/no) | 142 (7.4) (n = 1913) |
LAG3 protein levels (Ex 5), RFU | 4764 [3635, 6204] (n = 1913) |
Presence of calcium indicator (yes/no) | NA |
Agatston calcium score, phantom-adjusted | NA |
Common carotid intimal-medical thickness (mm) | NA |
Internal carotid intimal-medical thickness (mm) | NA |
Ankle-brachial index (ABI) (Gen 3) | 1.23 [1.18, 1.28] (n = 2609) |
Myocardial infarction (MI) (yes/no) | 97 (5.1) |
Follow-up time (days) | 7039 days |